Regdanvimab
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Regdanvimab, covering 2021-02-24 to 2023-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19 [Phase 4]